Description

Ciloxan (Ciprofloxacin Hydrochloride) Eye/Ear Drops 0.35% 5 ml

Ingredients

Active ingredient: Ciprofloxacin hydrochloride 0.35%. Other ingredients may include benzalkonium chloride, hydrochloric acid, and purified water.

Dosage

For adults and children: Instill 1 to 2 drops into the affected eye or ear every 4 hours. Consult a healthcare professional for proper usage instructions.

Indications

Ciloxan Eye/Ear Drops are indicated for the treatment of bacterial infections in the eyes and ears. It is commonly used for conditions like conjunctivitis and otitis externa.

Contraindications

Do not use Ciloxan Eye/Ear Drops if:

• You are allergic to ciprofloxacin or any other ingredients in the product.
• You have a history of hypersensitivity reactions to quinolones.
• You are pregnant or breastfeeding without consulting a doctor.

Directions

Follow these directions for proper use: Wash hands before use. Tilt the head back, pull the lower eyelid down, and apply the prescribed number of drops. Avoid touching the dropper tip to prevent contamination.

Scientific Evidence

Ciloxan (Ciprofloxacin Hydrochloride) Eye/Ear Drops have been extensively studied for their efficacy in treating bacterial infections. Research published in the Journal of Ophthalmology demonstrated the effectiveness of ciprofloxacin in resolving bacterial conjunctivitis with a high success rate.

Additional Information

Storage: Store the bottle tightly closed at room temperature away from light and moisture. Keep out of reach of children. Discard any remaining solution after the prescribed treatment duration.

Pharmacological Effects: Ciprofloxacin, the active ingredient in Ciloxan Eye/Ear Drops, exerts its antimicrobial action by inhibiting bacterial DNA gyrase, thereby disrupting DNA replication and leading to bacterial cell death.

Clinical Trials: Clinical trials have shown that Ciloxan Eye/Ear Drops are comparable in efficacy to other topical antibiotics in the treatment of bacterial eye and ear infections. A study published in the International Journal of Infectious Diseases demonstrated the high cure rates and safety profile of ciprofloxacin in these conditions.